Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody

Eribulin is a microtubule dynamics inhibitor with tumor microenvironment modulation activity such as vascular remodeling activity. Here, we investigated antitumor and immunomodulatory activities of eribulin and its liposomal formulation (eribulin-LF) as monotherapies or in combination with anti–prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Niwa, Yuki, Adachi, Keito, Tabata, Kimiyo, Ishida, Ryoga, Hotta, Koichiro, Ishida, Tomomi, Mano, Yuji, Ozawa, Yoichi, Minoshima, Yukinori, Funahashi, Yasuhiro, Semba, Taro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Large Molecule Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068443/
https://www.ncbi.nlm.nih.gov/pubmed/36696578
http://dx.doi.org/10.1158/1535-7163.MCT-22-0475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068443/
https://www.ncbi.nlm.nih.gov/pubmed/36696578
http://dx.doi.org/10.1158/1535-7163.MCT-22-0475

Ejemplares similares